Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

Clinical trial NCT06375161 · RECRUITING

Trial details

NCT number: NCT06375161
Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

B Cell Malignancies

Start date: 2023-12-11
Primary completion: 2025-12-10
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.